164 related articles for article (PubMed ID: 15531549)
21. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix.
Chun TH; Sabeh F; Ota I; Murphy H; McDonagh KT; Holmbeck K; Birkedal-Hansen H; Allen ED; Weiss SJ
J Cell Biol; 2004 Nov; 167(4):757-67. PubMed ID: 15545316
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
23. Membrane type 1-matrix metalloproteinase induces endothelial cell morphogenic differentiation by a caspase-dependent mechanism.
Langlois S; Di Tomasso G; Boivin D; Roghi C; Murphy G; Gingras D; Béliveau R
Exp Cell Res; 2005 Jul; 307(2):452-64. PubMed ID: 15882863
[TBL] [Abstract][Full Text] [Related]
24. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
25. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP.
Robinet A; Fahem A; Cauchard JH; Huet E; Vincent L; Lorimier S; Antonicelli F; Soria C; Crepin M; Hornebeck W; Bellon G
J Cell Sci; 2005 Jan; 118(Pt 2):343-56. PubMed ID: 15632106
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
27. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
28. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
29. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.
Pap T; Shigeyama Y; Kuchen S; Fernihough JK; Simmen B; Gay RE; Billingham M; Gay S
Arthritis Rheum; 2000 Jun; 43(6):1226-32. PubMed ID: 10857781
[TBL] [Abstract][Full Text] [Related]
30. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
31. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
[TBL] [Abstract][Full Text] [Related]
32. Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.
Koolwijk P; Kapiteijn K; Molenaar B; van Spronsen E; van der Vecht B; Helmerhorst FM; van Hinsbergh VW
J Clin Endocrinol Metab; 2001 Jul; 86(7):3359-67. PubMed ID: 11443212
[TBL] [Abstract][Full Text] [Related]
33. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.
Koolwijk P; Sidenius N; Peters E; Sier CF; Hanemaaijer R; Blasi F; van Hinsbergh VW
Blood; 2001 May; 97(10):3123-31. PubMed ID: 11342439
[TBL] [Abstract][Full Text] [Related]
34. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
35. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
36. Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer.
Sun YN; Li Y
Chin Med Sci J; 2004 Sep; 19(3):170-3. PubMed ID: 15506641
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT
Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
39. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H
J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
